BBBY worth buying ahead of earnings report tomorrow -- UBS 40.20 -0.05: UBS is positive on Bed, Bath & Beyond as the stock trades at only a 30% premium to an index of other leading retailers, at the bottom of its historical range that averages 55% and peaked at over 90%. The firm sees an attractive entry point ahead of the co's Q4 (Feb) report tomorrow afternoon. The firm's proprietary analysis indicates there is potential for almost twice the number of stores than mgmt projects. The firm sees the co as one of the strongest, most consistent growth retailers.
Market Data 
Markets 
AI
